PGR and breast carcinoma: The triple negative phenotype, defined as the lack of estrogen receptor, progesterone receptor and HER-2 expression, represents approximately 15-20 % of breast cancer cases and has a worse clinical outcome and prognosis than other breast cancer subtypes [1–5].